Navigation Links
Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast
Date:1/23/2010

PLEASANTON, Calif., Jan. 22 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the 2009 fiscal year on Thursday, January 28.

The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 1:30 p.m., Pacific Standard Time, (4:30 p.m., Eastern Standard Time), Thursday, January 28, hosted by Gary F. Burbach, president and chief executive officer, and David V. Smith, executive vice president and chief financial officer.

The teleconference can be accessed by calling (719) 325-2456, passcode 6302456. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available on the Internet at http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=95989&eventID=2683786, or at http://www.thoratec.com.

A replay of the conference call will be available through Thursday, February 4, via http://www.thoratec.com, or by telephone at (719) 457-0820, passcode 6302456.

Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec® VAD (Ventricular Assist Device) and HeartMate® LVAS (Left Ventricular Assist System), with more than 14,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division is a leader in point-of-care blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web sites at http://www.thoratec.com or http://www.itcmed.com.

SOURCE Thoratec Corporation

RELATED LINKS
http://www.thoratec.com
http://www.itcmed.com

'/>"/>

SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
2. Thoratec Presentation at Piper Jaffray Conference to be Webcast
3. Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast
4. Thoratec Presentation at Canaccord Adams Conference to be Webcast
5. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
6. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
7. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
8. Roper Industries Schedules Fourth Quarter 2009 Financial Results Conference Call
9. Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call
10. Misonix Schedules First Quarter 2010 Financial Results Conference Call; November 16, 2009 at 4:30 p.m. Eastern
11. VirtualScopics Schedules Third Quarter 2009 Earnings Announcement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , February 23, 2017 ... market: the Berlin office was ... Magdalena Kritikos . The portfolio includes Entocort ® ... for the treatment of ulcerative colitis, and VistaPrep ® ... solutions, the Swiss specialty pharmaceutical company focused on the ...
(Date:2/23/2017)... 2017 MabVax Therapeutics Holdings, Inc ... company, announces that it has received notice from ... the initiation a Phase I clinical trial with ... MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s novel ... initiate the phase I clinical trial in patients ...
(Date:2/23/2017)... 23, 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) ... oncology and dermatology biopharmaceutical company, today announced that it ... Rodrigues as special advisers to the Company,s Board ... the board on financial and corporate strategy. ... commitment of up to $2.5 million from Eric ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... The National Academy of Certified ... the April 2017 testing period. NACCM, a nonprofit organization, has provided the premier ... exam is periodically re-calibrated to ensure that newly certified professionals are prepared to ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... understand each Medicare Advantage member’s risk, identify any gaps-in-coding, as well as ... helps transform the HCC Risk Adjustment process from a typical fragmented process ...
(Date:2/22/2017)... ... February 22, 2017 , ... Doctors on Liens is continuing its steady ... Steven H. Rauchman, practicing at North Valley Eye Medical Group in Mission Hills ... liability and other personal injury cases. These injuries have a major impact on ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Using the ... leads utilizing a simple online checklist. Over a period of just 24 months, thousands ... assistance of an online checklist called T.A.D. , “The internet is not getting quieter. ...
(Date:2/22/2017)... ... February 22, 2017 , ... The Centers for ... help small practices in Delaware, New Jersey, Pennsylvania and West Virginia prepare for ... and CHIP Reauthorization Act of 2015 (MACRA). , This technical assistance, authorized ...
Breaking Medicine News(10 mins):